-
Something wrong with this record ?
Laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity in a series of 244 patients
M. Fried, K. Dolezalova, JN. Buchwald, TW. McGlennon, P. Sramkova, G. Ribaric,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2010-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
Public Health Database (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- Analysis of Variance MeSH
- Diabetes Mellitus, Type 2 blood complications physiopathology MeSH
- Gastroplasty adverse effects methods MeSH
- Weight Loss MeSH
- Body Mass Index MeSH
- Laparoscopy MeSH
- Middle Aged MeSH
- Humans MeSH
- Logistic Models MeSH
- Obesity, Morbid blood complications physiopathology surgery MeSH
- Follow-Up Studies MeSH
- Prospective Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a new metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report LGCP outcomes in 244 morbidly obese patients. METHODS: Between 2010 and 2011, patients underwent LGCP. Body mass index (BMI, kilogram per square meter) evolution, excess BMI loss (%EBMIL), excess weight loss (%EWL), complications, and type 2 diabetes mellitus (T2DM) changes were recorded. Repeated-measures analysis of variance (ANOVA) was used to assess weight change at 6, 12, and 18 months. Subgroup analyses were conducted to provide benchmark outcomes at 6 months. Logistic regression was used to identify characteristics predictive of suboptimal weight loss. RESULTS: Mean baseline BMI (±SD) was 41.4 ± 5.5 (80.7 % women, mean age 46.1 ± 11.0 years, 68 [27.9 %] patients had T2DM). Mean operative time was 70.6 min; mean hospitalization, 36 h (24-72). Sixty-eight patients (27.9 %) experienced postoperative nausea and/or vomiting that was controlled within 36 h. There was no mortality. Major complication rate was 1.2 % (n = 3). Repeated-measures ANOVA indicated significant weight loss across time points (p < 0.001). At 6 months (n = 105), BMI, %EBMIL, and %EWL were 36.1 ± 4.7, 34.8 ± 17.3, and 31.8 ± 15.9. Preoperative BMI was the only predictor of weight loss. Patients with BMI <40 lost more weight than those ≥40, although by 9 months, differences were no longer significant. In patients with preoperative BMI <40, 18-month %EWL approached 50 % and %EBMIL exceeded 50 %. At 6 months, 96.9 % of patients' T2DM was significantly improved/resolved. CONCLUSIONS: Over the short term, LGCP results in effective weight loss and significant T2DM reduction with a very low rate of complications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000766
- 003
- CZ-PrNML
- 005
- 20130221094025.0
- 007
- ta
- 008
- 130108s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11695-012-0684-2 $2 doi
- 035 __
- $a (PubMed)22648797
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fried, M $u First Faculty of Medicine, Charles University, Katerinska 32, 128 00 Prague 2, Czech Republic. docfried@volny.cz
- 245 10
- $a Laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity in a series of 244 patients / $c M. Fried, K. Dolezalova, JN. Buchwald, TW. McGlennon, P. Sramkova, G. Ribaric,
- 520 9_
- $a BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a new metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report LGCP outcomes in 244 morbidly obese patients. METHODS: Between 2010 and 2011, patients underwent LGCP. Body mass index (BMI, kilogram per square meter) evolution, excess BMI loss (%EBMIL), excess weight loss (%EWL), complications, and type 2 diabetes mellitus (T2DM) changes were recorded. Repeated-measures analysis of variance (ANOVA) was used to assess weight change at 6, 12, and 18 months. Subgroup analyses were conducted to provide benchmark outcomes at 6 months. Logistic regression was used to identify characteristics predictive of suboptimal weight loss. RESULTS: Mean baseline BMI (±SD) was 41.4 ± 5.5 (80.7 % women, mean age 46.1 ± 11.0 years, 68 [27.9 %] patients had T2DM). Mean operative time was 70.6 min; mean hospitalization, 36 h (24-72). Sixty-eight patients (27.9 %) experienced postoperative nausea and/or vomiting that was controlled within 36 h. There was no mortality. Major complication rate was 1.2 % (n = 3). Repeated-measures ANOVA indicated significant weight loss across time points (p < 0.001). At 6 months (n = 105), BMI, %EBMIL, and %EWL were 36.1 ± 4.7, 34.8 ± 17.3, and 31.8 ± 15.9. Preoperative BMI was the only predictor of weight loss. Patients with BMI <40 lost more weight than those ≥40, although by 9 months, differences were no longer significant. In patients with preoperative BMI <40, 18-month %EWL approached 50 % and %EBMIL exceeded 50 %. At 6 months, 96.9 % of patients' T2DM was significantly improved/resolved. CONCLUSIONS: Over the short term, LGCP results in effective weight loss and significant T2DM reduction with a very low rate of complications.
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x komplikace $x patofyziologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a gastroplastika $x škodlivé účinky $x metody $7 D015391
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laparoskopie $7 D010535
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a morbidní obezita $x krev $x komplikace $x patofyziologie $x chirurgie $7 D009767
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a hmotnostní úbytek $7 D015431
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dolezalova, K
- 700 1_
- $a Buchwald, J N
- 700 1_
- $a McGlennon, T W
- 700 1_
- $a Sramkova, P
- 700 1_
- $a Ribaric, G
- 773 0_
- $w MED00180469 $t Obesity surgery $x 1708-0428 $g Roč. 22, č. 8 (2012), s. 1298-307
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22648797 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20130221094218 $b ABA008
- 999 __
- $a ok $b bmc $g 963548 $s 798930
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 22 $c 8 $d 1298-307 $i 1708-0428 $m Obesity surgery $n Obes Surg $x MED00180469
- LZP __
- $a Pubmed-20130108